Cargando…
Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations
Glioblastoma (GBM) is the most common, malignant and aggressive brain tumour in adults. Despite the use of multimodal treatments, involving surgery, followed by concomitant radiotherapy and chemotherapy, the median survival for patients remains less than 15 months from diagnosis. Low penetration of...
Autores principales: | Vasey, Catherine E., Cavanagh, Robert J., Taresco, Vincenzo, Moloney, Cara, Smith, Stuart, Rahman, Ruman, Alexander, Cameron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913572/ https://www.ncbi.nlm.nih.gov/pubmed/33546301 http://dx.doi.org/10.3390/pharmaceutics13020208 |
Ejemplares similares
-
In Situ Gelling Systems for Drug Delivery
por: Kouchak, Maryam
Publicado: (2014) -
In-situ gelling polymers: for biomedical applications
por: Loh, Xian
Publicado: (2015) -
Formulation and Evaluation of Floating Oral In Situ Gelling System of Amoxicillin
por: Patel, Dasharath M., et al.
Publicado: (2011) -
Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
por: Yadav, Monika, et al.
Publicado: (2019) -
Nanoparticles laden in situ gelling system for ocular drug targeting
por: Kumar, Divya, et al.
Publicado: (2013)